Press Release- Page 44

REYKJAVIK, Iceland, Aug. 19, 2026 (GLOBE NEWSWIRE) — Alvotech (NASDAQ: ALVO; ALVO-SDB) (“Alvotech” or the “Company”), a global biotechnology company specializing in the development and manufacture of biosimilar medicines for patients worldwide,

Stable Operations and Ongoing Development of the Transmission System Landsnet’s operations were in line with expectations during the first half of the year, according to the company’s half-year financial results published today.